digital health startups weight loss glp-1 Beyond the Hype: Where and how Founders Should Build in the Market Digital health companies are launching
Description
doi: 10.1517/14656566.2010.497142
Blunted glucose-stimulated insulin secretion , compromising glycaemic control
The safety advantage of supplements like GLP-1 Complete is real and meaningful
Shortages of the semaglutide-based injectable diabetes medication Ozempic, which accounts for 40% of GLP-1R agonist US market share, have even emerged, driven by overwhelming demand for the weight loss formulation Wegovy , both for treatment of obesity and for short-term weight loss popularized by celebrities on social media
Holst et al ., 1987
